Key Takeaways
- Penrhos Bio has raised $4.1 million in Series A funding, with a focus on agtech applications for its anti-biofilm technology, Remora.
- The funding aims to accelerate the regulatory approval and commercialization of Remora in agricultural settings.
- Remora offers a sustainable alternative to traditional agricultural disinfectants and antimicrobial agents.
- Penrhos Bio is already collaborating with partners in the agtech sector to apply its technology.
- Eos Advisory, Earthbound Brands, and Scottish Enterprise led the Series A round.
Penrhos Bio, a biotechnology company focused on agtech, has secured $4.1 million in a Series A funding round. The investment aims to accelerate the regulatory submission and commercialization of Remora, the company’s anti-biofilm technology, in agricultural settings.
Funding and AgTech Focus
The funding will be used specifically to advance Remora’s applications in the agtech sector. “This investment will allow us to accelerate our regulatory activities in the agricultural sector, leading to active registration alongside building our brand value in Remora,” said Richard Hammond, Penrhos Bio’s Chief Executive.
Remora’s AgTech Applications
Developed in collaboration with Unilever, Remora protects agricultural surfaces against harmful bacteria, fungi, and algae. It provides a sustainable alternative to traditional agricultural disinfectants and antimicrobial agents.
AgTech Partnerships
Penrhos Bio is already collaborating with multiple corporate partners in the agtech sector to apply its Remora technology. “The next phase should see more product launches in the agtech sector as Penrhos moves through the necessary regulatory approval processes alongside its commercial partners,” Hammond stated.
